Hazlett, Burt & Watson’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23
Closed -$6K 933
2025
Q4
$6K Hold
23
﹤0.01% 767
2025
Q3
$6K Buy
23
+1
+5% +$263 ﹤0.01% 721
2025
Q2
$5K Hold
22
﹤0.01% 668
2025
Q1
$6K Hold
22
﹤0.01% 636
2024
Q4
$6K Sell
22
-45
-67% -$12.1K ﹤0.01% 601
2024
Q3
$22K Buy
67
+45
+205% +$16K 0.01% 451
2024
Q2
$8K Hold
22
﹤0.01% 539
2024
Q1
$8K Hold
22
﹤0.01% 535
2023
Q4
$10K Hold
22
0.01% 497
2023
Q3
$11K Sell
22
-12
-35% -$5.64K 0.01% 489
2023
Q2
$15K Hold
34
0.01% 439
2023
Q1
$17K Buy
+34
New +$16.8K 0.01% 404

Other funds holding HUM

Hazlett, Burt & Watson's HUM Position: Q1 2026 in Review

Hazlett, Burt & Watson sold out of Humana (HUM) in Q1 2026, closing a stake of 23 shares — an estimated $6K sold.

Hazlett, Burt & Watson first reported a position in HUM in Q1 2023 and held it in 12 quarters. The position peaked at $22K in Q3 2024. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Hazlett, Burt & Watson reported no remaining Humana position as of Q1 2026 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 23 Humana shares in Q1 2026, an estimated $6K.
  • Hazlett, Burt & Watson first reported a position in Humana in Q1 2023 and held it in 12 quarters.
  • Hazlett, Burt & Watson's Humana position peaked at $22K in Q3 2024.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.